Insider Trading News

HP world controller Stephanie Liebman sells $357,500 in inventory

Stephanie Liebman, the International Controller at HP Inc. (NYSE:HPQ), not too long ago offered 11,000 shares of the corporate's frequent…

3 weeks ago

L3Harris Applied sciences president sells $288,412 in inventory

Ross Niebergall, President of Aerojet Rocketdyne, a division of L3Harris Applied sciences (NYSE:LHX), not too long ago offered 1,373 shares…

3 weeks ago

Edgewise Therapeutics chief scientific officer sells $2.74 million in inventory

Russell Alan J, the Chief Scientific Officer of Edgewise Therapeutics, Inc. (NASDAQ:EWTX), not too long ago executed a major inventory…

3 weeks ago

Cross Nation Healthcare director Larry Money buys $61,320 in inventory

W. Larry Money, a director at Cross Nation Healthcare Inc. (NASDAQ:CCRN), has made notable purchases of the corporate's frequent inventory,…

3 weeks ago

Asa Gold & Valuable Metals COO Merk Alexander buys $487k in inventory

In a latest transaction, Merk Alexander, Chief Working Officer of ASA Gold & Valuable Metals Ltd (NYSE:ASA), acquired a big…

3 weeks ago

Encourage veterinary companions director Timothy Watters sells shares for $84

Timothy Watters, a director at Encourage Veterinary Companions, Inc. (NASDAQ:IVP), just lately offered 467 shares of the corporate's Class A…

3 weeks ago

PNC Monetary CEO William Demchak sells $240,476 in inventory

William S. Demchak, the CEO of PNC Monetary Companies Group, Inc. (NYSE:PNC), a distinguished banking establishment with a market capitalization…

3 weeks ago

Cls Holdings USA shareholder sells $30,000 in inventory

In a current transaction reported to the Securities and Trade Fee, Haldan Patrick Stibbs, a big shareholder of CLS Holdings…

3 weeks ago

Cls Holdings director Silver Ross sells $39,937 in shares

Silver Ross, a director at CLS Holdings USA, Inc. (OTC:CLSH), has bought a good portion of his shares within the…

3 weeks ago

Gyre Therapeutics president Ma Songjiang sells $50,553 in inventory

SAN DIEGO—Ma Songjiang, President and Director of Gyre Therapeutics, Inc. (NASDAQ:GYRE), reported promoting a complete of $50,553 value of frequent…

3 weeks ago